Malcolm Salter C4 Therapeutics, Inc. (CCCC) insider trading activity

Malcolm Salter is Director of C4 Therapeutics, Inc.. Currently has a direct ownership of 11,380 shares of CCCC, which is worth approximately $43,130. The most recent transaction as insider was on Jan 04, 2022, when has been sold 428 shares (Common Stock) at a price of $31.58 per share, resulting in proceeds of $13,516. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.4K

0% 3M change

0% 12M change

Total Value Held $43,130

Malcolm Salter Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 04 2022	BUY Grant, award, or other acquisition	$13,516 $31.58 p/Share	428 Added 3.62%	11,380 Common Stock
Dec 17 2021	SELL Open market or private sale	$22,839 $30.25 p/Share	755 Reduced 6.45%	10,952 Common Stock
Nov 19 2021	SELL Open market or private sale	$30,283 $40.11 p/Share	755 Reduced 6.06%	11,707 Common Stock
Oct 15 2021	SELL Open market or private sale	$33,930 $44.94 p/Share	755 Reduced 5.71%	12,462 Common Stock
Oct 04 2021	BUY Grant, award, or other acquisition	$13,497 $44.99 p/Share	300 Added 2.22%	13,217 Common Stock
Sep 17 2021	SELL Open market or private sale	$37,667 $49.89 p/Share	755 Reduced 5.52%	12,917 Common Stock
Aug 20 2021	SELL Open market or private sale	$30,751 $40.73 p/Share	755 Reduced 5.23%	13,672 Common Stock
Jul 16 2021	SELL Open market or private sale	$28,214 $37.37 p/Share	755 Reduced 4.97%	14,427 Common Stock
Jul 02 2021	BUY Grant, award, or other acquisition	$13,465 $39.72 p/Share	339 Added 2.18%	15,182 Common Stock
Jun 18 2021	SELL Open market or private sale	$28,078 $37.19 p/Share	755 Reduced 4.84%	14,843 Common Stock
May 21 2021	SELL Open market or private sale	$28,026 $37.12 p/Share	755 Reduced 4.62%	15,598 Common Stock
Apr 05 2021	BUY Grant, award, or other acquisition	$13,466 $37.51 p/Share	359 Added 2.15%	16,353 Common Stock
Oct 06 2020	BUY Open market or private purchase	$24,985 $19.0 p/Share	1,315 Added 7.6%	15,994 Common Stock
Oct 06 2020	BUY Conversion of derivative security	-	14,679 Added 50.0%	14,679 Common Stock

Malcolm Salter

Director

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Value

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

Operation

Value

Type

News

Receive news related to C4 Therapeutics, Inc.

Track Activities on CCCC

Account